Generic drugs

Aurobindo Pharma’s shares closed with a loss of 3.7% as investors feared it may face delays in resolving the issue. Graphic: Naveen Kumar Saini/Mint

US FDA: a risk that keeps on giving

3 min read . 06 Mar 2018